Brief: Genscript Biotech Says Probio Cayman Agreed To Sell And Issue Total Of 300 Mln Series A Preferred Shares For About US$150 Mln

Genscript Biotech

19/08/2021 02:23

Aug 19 (Reuters) - Genscript Biotech Corp  1548.HK :
    * PROBIO CAYMAN AGREED TO SELL AND ISSUE TOTAL OF 300
MILLION
SERIES A PREFERRED SHARES FOR ABOUT US$150 MILLION
    * PROBIO WARRANT TO PURCHASE 189.4 MILLION PROBIO SHARES AT
AGGREGATE CONSIDERATION OF ABOUT US$125.0 MILLION AT CLOSING

Source text for Eikon:  ID:nHKS5Jcr24 
Further company coverage:  1548.HK 

 ((Reuters.Briefs@thomsonreuters.com;))